iBio (IBIO) Change in Accured Expenses (2016 - 2025)

iBio (IBIO) has disclosed Change in Accured Expenses for 16 consecutive years, with $567000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 6987.5% to $567000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67000.0 through Dec 2025, up 103.75% year-over-year, with the annual reading at -$758000.0 for FY2025, 56.08% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $567000.0 at iBio, up from -$686000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.4 million in Q4 2022, with the low at -$1.3 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is $40050.0, with a median of $52000.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses plummeted 1407.29% in 2023, then soared 6987.5% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $791000.0 in 2021, then surged by 204.05% to $2.4 million in 2022, then plummeted by 100.29% to -$7000.0 in 2023, then skyrocketed by 214.29% to $8000.0 in 2024, then skyrocketed by 6987.5% to $567000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $567000.0, -$686000.0, and -$54000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.